AVNS
Avanos Medical, Inc.
NYSE · Healthcare · Medical - Devices · US
$24.99
+0.04%Price chart
Jun 24Jun 29Jul 2Jul 8Jul 13Jul 16Jul 21Jul 24
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−57.6x
Market Cap
$1.17B
MomentumView details →
1D Return
+0.04%
YTD Return
+122.53%
RSI (14)
62.1
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−57.6x
Market Cap
$1.17B
RSI (14)
62.1
MomentumView details →
1D Return
+0.04%
YTD Return
+122.53%
SummaryUpdated Mar 1, 2026
Avanos Medical, Inc. (NYSE:AVNS) is a medical technology company founded in 2014 as a spinoff from Kimberly-Clark Corporation, initially operating under the name Halyard Health before rebranding to Avanos Medical in 2018. The company is headquartered in Alpharetta, Georgia, and focuses on developing and manufacturing medical devices for chronic care, pain management, and specialty nutrition applications. Avanos serves healthcare providers across North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America, with a portfolio designed to improve patient outcomes in hospital and home care settings.
Similar companies
Latest newsMore news →